SCHEMBL14301421

SCHEMBL14301421

COC(=O)c1cc(C(C)=O)cc(C(=O)O)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.52
CA1 P00915 3/20 0.52
CA2 P00918 3/20 0.52
CA7 P43166 3/20 0.52
CA9 Q16790 3/20 0.52
CA14 Q9ULX7 3/20 0.52
KDM4E B2RXH2 6/20 0.52
ALDH1A1 P00352 1/20 0.52
LMNA P02545 3/20 0.50
XDH P47989 2/20 0.50
POLB P06746 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
GAA P10253 1/20 0.50
NFKB1 P19838 1/20 0.50
GFER P55789 1/20 0.50
NFKB2 Q00653 1/20 0.50
RELA Q04206 1/20 0.50
FUT7 Q11130 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
TSHR P16473 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7234945 0.91 CA12 (0.60) CA12CA1CA2CA7CA9
SCHEMBL9121827 0.91 CA12 (0.60) CA12CA1CA2CA7CA9
SCHEMBL4731536 0.91 CA1 (0.60) CA12CA1CA2CA7CA9
Methyl Alcohol SCHEMBL28269742 0.89 CA12 (0.58) CA12CA1CA2CA7CA9
SCHEMBL11762568 0.84 TPMT (0.55) CA12CA1CA2CA7CA9
SCHEMBL9350174 0.84 TPMT (0.55) CA12CA1CA2CA7CA9
SCHEMBL14293378 0.84 KDM4E (0.48) CA12CA1CA2CA7CA9
SCHEMBL2624952 0.83 CA12 (0.76) CA12CA1CA2CA7CA9
SCHEMBL3351858 0.83 ATM (0.53) CA12CA1CA2CA7CA9
SCHEMBL166126 0.83 TPMT (0.64) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230039858-A1 COMPOSITIONS AND METHODS RELATED TO MOLECULAR CONJUGATION INTOCELL, INC. (KR) 2023-02-09 US disclosed
WO-2021111185-A1 COMPOSITIONS AND METHODS RELATED TO MOLECULAR CONJUGATION INTOCELL, INC. (KR) 2021-06-10 WO disclosed
US-20170107562-A1 METHODS FOR NUCLEIC ACID SEQUENCING Quantum-Si Incorporated (US) 2017-04-20 US disclosed
US-20080038832-A1 Method for Producing Molecularly Imprinted Polymers for the Recognition of Target Molecules MIP TECHNOLOGIES AB 2008-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230039858-A1 COMPOSITIONS AND METHODS RELATED TO MOLECULAR CONJUGATION FCGR2A, FCGRT, FCGR3B CA12 1261/4885CA1 2558/4885CA2 4111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.